Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics Inc (NQ: OTLK )

8.500 -0.420 (-4.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 193,903
Open 8.930
Bid (Size) 8.550 (10)
Ask (Size) 8.700 (17)
Prev. Close 8.920
Today's Range 8.490 - 9.123
52wk Range 0.2002 - 12.85
Shares Outstanding 260,257,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks. 
Via InvestorPlace
Insiders Buying Outlook Therapeutics And 2 Other Stocks
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
+2062.30%
+2062.30%
1 Month
-17.15%
-17.15%
3 Month
+1948.19%
+1948.19%
6 Month
+1316.67%
+1316.67%
1 Year
+626.50%
+626.50%

More News

Read More
Gold Moves Lower; Lululemon Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
7 of the Best Speculative Stocks You Can Snag for Less Than $1
Via InvestorPlace
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK
From The Rosen Law Firm, P.A.
Via Business Wire
OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
From The Rosen Law Firm PA
Via GlobeNewswire
OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
OTLK DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
OTLK DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outlook Therapeutics, Inc. (OTLK)
From The Law Offices of Frank R. Cruz
Via Business Wire
OTLK Stock Earnings: Outlook Therapeutics Reported Results for Q4 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.